SAFETY AND PERSISTENCE OF TREATMENT WITH GOLIMUMAB VERSUS CERTOLIZUMAB IN RHEUMATOID ARTHRITIS: RESULTS FROM BIOBADABRASIL COHORT STUDY.
| Autor: | Bredemeier, M., Ramos, S., Solórzano, C., Duarte, A., Pinheiro, M., Stadler, B., Macieira, J. C., Ranza, R., Miranda, J., Valim, V., Castro, G., Bertolo, M., Sauma, M. D. F., Fernandes, V., Medeiros-Ribeiro, A. C., Botelho, R., Brenol, C., De Carvalho, H. M. Da Silveira, Studart, S., Pinheiro, G. Da Rocha Castelar |
|---|---|
| Zdroj: | Annals of the Rheumatic Diseases; 2023 Supplement, Vol. 82, p1402-1403, 2p |
| Databáze: | Complementary Index |
| Externí odkaz: |
|